Position in LH
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$316,400
+$15,972 QoQ
Shares Held
1,130
+0.4% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
#691
of 1,040 holders
Holding Since
Mar 2025
4 quarters on record
Voting authority
Sole 0%
Shared 100%
None 0%
Common Shares in LH Over Time
Shares Held
Position Value (USD)
Position in Diagnostics & Research
Healthcare · as of Jun 30, 2026PRELUDE CAPITAL MANAGEMENT, LLC holds $11,334,331 across 9 Diagnostics & Research names. LH ranks #8 (2.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | SHC |
Sotera Health Co
|
208,430 | $3,699,632 | |
| 2 | TMO |
Thermo Fisher Scientific Inc.
|
5,752 | $2,883,822 | |
| 3 | TWST |
Twist Bioscience Corp
|
18,976 | $1,952,250 | |
| 4 | FLGT |
Fulgent Genetics, Inc.
|
51,698 | $1,060,842 | |
| 5 | IDXX |
Idexx Laboratories Inc /De
|
809 | $425,889 | |
| 6 | DHR |
Danaher Corp /De/
|
2,072 | $394,674 | |
| 7 | NTRA |
Natera, Inc.
|
1,428 | $387,630 | |
| 8 | LH |
Labcorp Holdings Inc.
This page
|
1,130 | $316,400 |
All Filings in LH
Export CSV
4 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $316,400 | 1,130 | Shares | Other | 2026-08-14 | |
| 2026-03-31 | $300,428 | 1,126 | Shares | Other | 2026-05-15 | |
| 2025-12-31 | $377,825 | 1,506 | Shares | Other | 2026-02-17 | |
| 2025-03-31 | $221,568 | 952 | Shares | Other | 2025-05-15 | |
| No filing history on record for this holder in this stock. | ||||||